abstract |
The present invention relates generally to compounds capable of modulating the activity of a protein serine/threonine phosphatase. The compounds can be used to treating conditions associated with protein serine/threonine phosphatase activity. The invention also relates to methods for screening compounds capable of modulating the activity of a protein serine/threonine phosphatase. |